Ahn-Gook Pharmaceutical Co. Ltd (001540) — Capital Reinvestment Ratio
Ahn-Gook Pharmaceutical Co. Ltd (001540) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩14.44 Billion) in capital expenditures (₩2.76 Billion). See 001540 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ahn-Gook Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Ahn-Gook Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Ahn-Gook Pharmaceutical Co. Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Ahn-Gook Pharmaceutical Co. Ltd from 2012 to 2024. For live market cap and broader valuation context, see Ahn-Gook Pharmaceutical Co. Ltd (001540) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 15.44x | ₩4.91 Billion | ₩75.89 Billion | ▲ +842.3% |
| 2022 | 1.64x | ₩1.79 Billion | ₩2.93 Billion | ▼ -40.2% |
| 2021 | 2.74x | ₩1.47 Billion | ₩4.04 Billion | ▲ +27.2% |
| 2020 | 2.16x | ₩11.19 Billion | ₩24.12 Billion | ▲ +1173.0% |
| 2019 | 0.17x | ₩22.08 Billion | ₩3.74 Billion | ▼ -38.3% |
| 2017 | 0.27x | ₩17.46 Billion | ₩4.79 Billion | ▼ -20.9% |
| 2016 | 0.35x | ₩12.62 Billion | ₩4.38 Billion | ▲ +184.5% |
| 2015 | 0.12x | ₩19.11 Billion | ₩2.33 Billion | ▼ -97.8% |
| 2014 | 5.56x | ₩1.29 Billion | ₩7.16 Billion | ▲ +207.2% |
| 2013 | 1.81x | ₩3.64 Billion | ₩6.60 Billion | ▲ +708.3% |
| 2012 | 0.22x | ₩11.51 Billion | ₩2.58 Billion | — |